GlassScriptPhysician profile
Leigh Ann Doane
NPI 1174960256
$12,439.20
in general payments reported to CMS, 2019-2025
37 companies · $8,456 in 2025
The $8,456 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $921 · 2020: $313 · 2021: $200 · 2022: $535 · 2023: $1,758 · 2024: $256 · 2025: $8,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,175 · Travel and Lodging: $2,734 · Food and Beverage: $1,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,174.99 |
| Travel and Lodging | $2,734.25 |
| Food and Beverage | $1,560.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,022.73 | 2025 | |
| Applied Medical Resources Corporation | $855.90 | 2023 | Gelpoint V-Path |
| Abbvie INC. | $582.77 | 2019-2024 | |
| Hologic Sales and Service, LLC | $281.62 | 2019-2024 | Aptima, Fluent Fluid Management System |
| Astellas Pharma US INC | $267.88 | 2019-2025 | Myrbetriq, Veozah |
| Minerva Surgical, INC | $239.81 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $197.65 | 2019-2025 | |
| Exeltis, USA INC. | $186.27 | 2020-2025 | Slynd |
| Lupin INC. | $176.97 | 2019 | |
| Mayne Pharma Commercial LLC | $156.49 | 2021-2025 | |
| Pfizer INC. | $151.46 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $132.40 | 2023-2025 | Myfembree, Gemtesa |
| Sage Therapeutics, LLC | $125.68 | 2020-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $115.97 | 2019 | |
| Myovant Sciences INC. | $108.94 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $97.96 | 2022 | |
| Amag Pharmaceuticals, INC. | $81.59 | 2019 | |
| Gynesonics, INC. | $80.05 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Duchesnay USA Incorporated | $63.92 | 2019-2020 | |
| Therapeuticsmd, INC. | $62.95 | 2019-2022 | |
| Agile Therapeutics, INC. | $55.38 | 2022-2023 | Twirla |
| Dexcom, INC. | $42.14 | 2025 | Dexcom G6 Transmitter |
| Millicent US INC | $41.65 | 2025 | Femlyv, Intrarosa |
| Axsome Therapeutics, INC. | $39.88 | 2025 | Auvelity |
| Organon LLC | $33.45 | 2024-2025 | Nexplanon |
| Exact Sciences Corporation | $31.99 | 2024-2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $29.31 | 2021-2023 | Balcoltra |
| Mylan Pharmaceuticals INC. | $26.95 | 2020-2021 | |
| Ethicon US, LLC | $20.35 | 2019 | |
| Almatica Pharma LLC | $20.16 | 2025 | Loreev Xr |
| Supernus Pharmaceuticals, INC. | $18.20 | 2025 | Qelbree |
| Shield Therapeutics INC | $17.42 | 2024 | |
| Evofem Biosciences, INC. | $15.12 | 2021 | |
| Davol INC. | $14.94 | 2022 | |
| Kci USA, INC. | $14.89 | 2023 | Prevena |
| Indivior INC. | $14.57 | 2024 | Sublocade |
| Meditrina | $13.79 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leigh Doane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.